{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T14:38:28Z","timestamp":1774449508062,"version":"3.50.1"},"reference-count":33,"publisher":"Galenos Yayinevi","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["FVVO"],"DOI":"10.52054\/fvvo.2026.323","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:16:16Z","timestamp":1773832576000},"page":"18-24","source":"Crossref","is-referenced-by-count":0,"title":["The past, present and future of uterine fibroids"],"prefix":"10.52054","volume":"18","author":[{"given":"Fred","family":"Burbank","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George A.","family":"Vilos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelos G.","family":"Vilos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2811","published-online":{"date-parts":[[2026,3,18]]},"reference":[{"key":"ref0","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1093\/humrep\/deae005","article-title":"Bipedalism and the dawn of uterine fibroids","volume":"39","author":"Vilos","year":"2024","unstructured":"1. Vilos GA, Vilos AG, Burbank F. Bipedalism and the dawn of uterine fibroids. Hum Reprod. 2024;39:454-63.","journal-title":"Hum Reprod"},{"key":"ref1","doi-asserted-by":"publisher","first-page":"3948","DOI":"10.3390\/jcm9123948","article-title":"Uterine fibroids and progestogen treatment: lack of evidence of its effi-cacy: a review","volume":"9","author":"Donnez","year":"2020","unstructured":"2. Donnez J. Uterine fibroids and progestogen treatment: lack of evidence of its effi-cacy: a review. J Clin Med. 2020;9:3948.","journal-title":"J Clin Med"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1097\/CM9.0000000000002971","article-title":"Global and regional trends in the inci-dence and prevalence of uterine fibroids and attributable risk factors at the natio-nal level from 2010 to 2019: a worldwide database study","volume":"137","author":"Dai","year":"2024","unstructured":"3. Dai Y, Chen H, Yu J, Cai J, Lu B, Dai M, et al. Global and regional trends in the inci-dence and prevalence of uterine fibroids and attributable risk factors at the natio-nal level from 2010 to 2019: a worldwide database study. Chin Med J (Engl). 2024;137:2583-9.","journal-title":"Chin Med J (Engl)"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1055\/s-0035-1563602","article-title":"Stem cells in myometrial physiology","volume":"33","author":"Ono","year":"2015","unstructured":"4. Ono M, Maruyama T. Stem cells in myometrial physiology. Semin Reprod Med. 2015;33:350-6.","journal-title":"Semin Reprod Med"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"5. Burbank F. Childbirth and myoma treatment by uterine artery occlusion: do they share a common biology? J Am Assoc Gynecol Laparosc. 2004;11:138-52.","DOI":"10.1016\/S1074-3804(05)60189-2"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1111\/1471-0528.14640","article-title":"Epidemiology of uterine fibroids: a systematic review","volume":"124","author":"Stewart E","year":"2017","unstructured":"6. Stewart E A, Cookson CL, Gandolfo RA, Schulze-Rath R. Epidemiology of uterine fibroids: a systematic review. BJOG. 2017;124:1501-12.","journal-title":"BJOG"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1001\/jama.2021.0278","article-title":"Trends in age at natural menopause and reproductive life span among us women, 1959-2018","volume":"325","author":"Appiah","year":"2021","unstructured":"7. Appiah D, Nwabuo CC, Ebong IA, Wellons MF, Winters SJ. Trends in age at natural menopause and reproductive life span among us women, 1959-2018. JAMA. 2021;325:1328-30.","journal-title":"JAMA"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1210\/endrev\/bnab039","article-title":"Comprehensive review of uterine fibroids: developmental origin, pathogenesis, and treatment","volume":"43","author":"Yang","year":"2022","unstructured":"8. Yang Q, Ciebiera M, Bariani MV, Ali M, Elkafas H, Boyer TG, et al. Comprehensive review of uterine fibroids: developmental origin, pathogenesis, and treatment. Endocr Rev. 2022 ;43:678-719.","journal-title":"Endocr Rev"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"120238","DOI":"10.1016\/j.lfs.2021.120238","article-title":"Differential response to hypoxia in leiomyoma and myometrial cells","volume":"290","author":"Miyashita-Ishiwata","year":"2022","unstructured":"9. Miyashita-Ishiwata M, El Sabeh M, Reschke LD, Afrin S, Borahay MA. Differential response to hypoxia in leiomyoma and myometrial cells. Life Sci. 2022;290:120238.","journal-title":"Life Sci"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.ajog.2005.12.059","article-title":"A new hypothesis about the origin of uteri-ne fibroids based on gene expression profiling with microarrays","volume":"195","author":"Leppert","year":"2006","unstructured":"10. Leppert PC, Catherino WH, Segars JH. A new hypothesis about the origin of uteri-ne fibroids based on gene expression profiling with microarrays. Am J Obstet Gy-necol. 2006;195:415-20.","journal-title":"Am J Obstet Gy-necol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s00441-015-2324-3","article-title":"Possib-le involvement of inflammatory\/reparative processes in the development of uteri-ne fibroids","volume":"364","author":"Protic","year":"2016","unstructured":"11. Protic O, Toti P, Islam MS, Occhini R, Giannubilo SR, Catherino WH, et al. Possib-le involvement of inflammatory\/reparative processes in the development of uteri-ne fibroids. Cell Tissue Res. 2016;364:415-27.","journal-title":"Cell Tissue Res"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.fertnstert.2022.06.028","article-title":"Natural history of fibroids in pregnancy: National Institute of Child Health and Human Development Fetal Growth Studies - Singletons cohort","volume":"118","author":"Mitro","year":"2022","unstructured":"12. Mitro SD, Peddada S, Chen Z, Buck Louis GM, Gleason JL, Zhang C, et al. Natural history of fibroids in pregnancy: National Institute of Child Health and Human Development Fetal Growth Studies - Singletons cohort. Fertil Steril. 2022;118:656-65.","journal-title":"Fertil Steril"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.1016\/j.fertnstert.2010.03.035","article-title":"Pregnancy-related fibroid reduction","volume":"94","author":"Laughlin","year":"2010","unstructured":"13. Laughlin SK, Herring AH, Savitz DA, Olshan AF, Fielding JR, Hartmann KE, et al. Pregnancy-related fibroid reduction. Fertil Steril. 2010;94:2421-3.","journal-title":"Fertil Steril"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.ajog.2011.02.018","article-title":"Postpartum factors and natural fibroid reg-ression","volume":"204","author":"Laughlin","year":"2011","unstructured":"14. Laughlin SK, Hartmann KE, Baird DD. Postpartum factors and natural fibroid reg-ression. Am J Obstet Gynecol. 2011;204:496.","journal-title":"Am J Obstet Gynecol"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"15. Coutinho LM, Assis WA, Spagnuolo-Souza A, Reis FM. Uterine fibroids and preg-nancy: how do they affect each other? Reprod Sci. 2022;29:2145-51.","DOI":"10.1007\/s43032-021-00656-6"},{"key":"ref15","unstructured":"16. Burbank F, Hutchins FL. Uterine artery occlusion by embolization or surgery for the treatment of fibroids: a unifying hypothesis-transient uterine ischemia. J Am Assoc Gynecol Laparosc. 2000;7(4 Suppl):S1-S49."},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1016\/0002-9378(90)90006-S","article-title":"Changes in hemostasis activity during delivery and the immediate postpartum period","volume":"162","author":"Gerbasi","year":"1990","unstructured":"17. Gerbasi FR, Bottoms S, Farag A, Mammen EF. Changes in hemostasis activity during delivery and the immediate postpartum period. Am J Obstet Gynecol. 1990;162:1158-63.","journal-title":"Am J Obstet Gynecol"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"18. Burbank F. Are fibroids that become endocavitary after uterine artery emboliza-tion necessarily a complication? AJR Am J Roentgenol. 2008;190:1227-30.","DOI":"10.2214\/AJR.07.3545"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"1346","DOI":"10.1186\/s12889-022-13656-1","article-title":"Global trends in total fertility ra-te and its relation to national wealth, life expectancy and female education","volume":"22","author":"Cheng","year":"2022","unstructured":"19. Cheng H, Luo W, Si S, Xin X, Peng Z, Zhou H, et al. Global trends in total fertility ra-te and its relation to national wealth, life expectancy and female education. BMC Public Health. 2022;22:1346.","journal-title":"BMC Public Health"},{"key":"ref19","unstructured":"20. Lewis-Kraus G. The end of children. The New Yorker [Internet]. Available from: https:\/\/www.newyorker.com\/magazine\/2025\/03\/03\/the-population-implosion (newyorker.com)"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.1016\/S0140-6736(24)00550-6","article-title":"Global fertility in 204 countries and terri-tories, 1950-2021, with forecasts to 2100: a comprehensive demographic analy-sis for the Global Burden of Disease Study 2021","volume":"403","author":"Fertility Forecasting Collaborators","year":"2024","unstructured":"21. GBD Fertility Forecasting Collaborators. Global fertility in 204 countries and terri-tories, 1950-2021, with forecasts to 2100: a comprehensive demographic analy-sis for the Global Burden of Disease Study 2021. Lancet 2024;403:2057-99.","journal-title":"Lancet"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"22. Xiao C, Wu X, Gallagher CS, Rasooly D, Jiang X, Morton CC. Genetic contribution of reproductive traits to risk of uterine leiomyomata: a large-scale, genome-wide, cross-trait analysis. Am J Obstet Gynecol. 2024;230:438.e1-438.e15.","DOI":"10.1016\/j.ajog.2023.12.040"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"23. Wang H, Li C, Chen L, Zhang M, Ren T, Zhang S. Causal relationship between fe-male reproductive factors, sex hormones and uterine leiomyoma: a Mendelian randomization study. Reprod Biomed Online. 2024;48:103584. Available from: https:\/\/www.bgsu.edu\/content\/dam\/BGSU\/college-of-arts-and-sciences\/NCFMR\/documents\/FP\/schweizer-guzzo-distributions-age-first-birth-fp-20-11.pdf","DOI":"10.1016\/j.rbmo.2023.103584"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"24. Schweizer VJ, Guzzo KB. Distributions of age at first birth, 1960-2018. Family Pro-files. 2020;FP-20-11. Bowling Green (OH): National Center for Family & Marriage Research.","DOI":"10.25035\/ncfmr\/fp-20-11"},{"key":"ref24","unstructured":"25. Statistics Canada. (2024, May 27). Fewer new moms, older new moms: A look at recent fertility trends in Canada. Statistics Canada. Available from: https:\/\/www.statcan.gc.ca\/o1\/en\/plus\/6310-fewer-newmoms-older-new-moms-look-recent-fertility-trends-canada?utm_source=openai"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"26. Vilos GA, Hollett-Caines J, Burbank F. Uterine artery occlusion: what is the evi-dence? Clin Obstet Gynecol. 2006;49:798-810.","DOI":"10.1097\/01.grf.0000211950.74583.f5"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"27. Sivin I, Stern J. Health during prolonged use of levonorgestrel 20 micrograms\/d and the copper TCu 380Ag intrauterine contraceptive devices: a multicenter study. International Committee for Contraception Research (ICCR). Fertil Steril. 1995;61:70-7.","DOI":"10.1016\/S0015-0282(16)56455-3"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/ajp.20947","article-title":"Diagnosis and prevalence of uterine leiomyomata in female chimpanzees (Pan troglodytes)","volume":"73","author":"Videan","year":"2011","unstructured":"28. Videan EN, Satterfield WC, Buchl S, Lammey ML. Diagnosis and prevalence of uterine leiomyomata in female chimpanzees (Pan troglodytes). Am J Primatol. 2011;73:665-70.","journal-title":"Am J Primatol"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1111\/j.1471-0528.1996.tb09911.x","article-title":"Protective effect of depot-medroxyprogesterone acetate on surgi-cally treated uterine leiomyomas: a multicentre case-control study","volume":"103","author":"Lumbiganon","year":"1996","unstructured":"29. Lumbiganon P, Rugpao S, Phandhu-fung S, Laopaiboon M, Vudhikamraksa N, Werawatakul Y. Protective effect of depot-medroxyprogesterone acetate on surgi-cally treated uterine leiomyomas: a multicentre case-control study. Br J Obstet Gynaecol. 1996;103:909-14.","journal-title":"Br J Obstet Gynaecol"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1093\/aje\/kwh016","article-title":"Reproductive factors, hormonal contraception, and risk of uterine leiom-yomata in African-American women: a prospective study","volume":"159","author":"Wise","year":"2004","unstructured":"30. Wise LA, Palmer JR, Harlow BL, Spiegelman D, Stewart EA, Adams-Campbell LL, et al. Reproductive factors, hormonal contraception, and risk of uterine leiom-yomata in African-American women: a prospective study. Am J Epidemiol. 2004;159:113-23.","journal-title":"Am J Epidemiol"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1093\/humrep\/dev069","article-title":"Use of depot medroxyprogesterone acetate and prevalent leiomyoma in young African American women","volume":"30","author":"QE","year":"2015","unstructured":"31. Harmon QE, Baird DD. Use of depot medroxyprogesterone acetate and prevalent leiomyoma in young African American women. Hum Reprod. 2015;30:1499-504.","journal-title":"Hum Reprod"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1097\/AOG.0000000000004745","article-title":"Depot med-roxyprogesterone acetate use and the development and progression of uterine le-iomyoma","volume":"139","author":"Harmon","year":"2022","unstructured":"32. Harmon QE, Patchel SA, Zhao S, Umbach DM, Cooper TE, Baird DD. Depot med-roxyprogesterone acetate use and the development and progression of uterine le-iomyoma. Obstet Gynecol. 2022;139:797-807.","journal-title":"Obstet Gynecol"},{"key":"ref32","unstructured":"33. Burbank F. Fibroids, menstruation, childbirth, and evolution: the fascinating story of uterine blood vessels. Tucson (AZ): Wheatmark Publishing; 2009. 291 p."}],"container-title":["Facts Views and Vision in ObGyn"],"original-title":[],"deposited":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T13:30:20Z","timestamp":1774445420000},"score":1,"resource":{"primary":{"URL":"https:\/\/fvvo.eu\/articles\/the-past-present-and-future-of-uterine-fibroids\/doi\/FVVO.2026.323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,18]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3,18]]}},"URL":"https:\/\/doi.org\/10.52054\/fvvo.2026.323","relation":{},"ISSN":["2032-0418","2684-4230"],"issn-type":[{"value":"2032-0418","type":"print"},{"value":"2684-4230","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,18]]}}}